$QNT

BHATIA MANISH H purchased $1.2M of QNT

BHATIA MANISH H purchased 20,000 shares of Quantinuum Inc. (QNT) at $60.00 ($1.20M total) on 2026-06-05.

Original reporting
SEC EDGAR · BHATIA MANISH H
Published Jun 8, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 8, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$QNT
Bullish
low confidence
Mentioned
$QNT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QNTBullishLow
01

Why it matters

The disclosure adds incremental sentiment information but does not introduce new company fundamentals (no earnings, guidance, contract, or regulatory action).

02

Market read

Traders may treat the filing as a small positive sentiment datapoint, but it is unlikely to drive a major repricing without additional catalysts.

03

What to watch

No 10b5-1 plan is cited, but the article also provides no context on prior trading patterns, option exercises, or whether the director’s compensation/vesting schedule drove the purchase.

Relevance 7/10Novelty 6/10Timing: Filed 2026-06-08 (covers purchase dated 2026-06-05).

Background

The article reports a Quantinuum (QNT) insider ownership change via SEC Form 4 (open-market purchase by a director).

Company-level read

Ticker impact

$QNTBullishLow confidence
Context

Director Manish H. Bhatia bought 20,000 shares of Quantinuum (QNT) for $1.2M via an open-market purchase disclosed on Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small.

Evidence & confidence

The filing is a Form 4 insider transaction with no accompanying operational/regulatory update; insider buys often have weak standalone price follow-through.

Market effects

No sector read-through; this is a single-company insider transaction without new guidance or product/regulatory developments.

None indicated.

None indicated.

Counterpoint

The buy may reflect diversification or personal liquidity planning rather than a strong forward-looking view; Form 4s are often noisy signals.

Key entities

  • Quantinuum Inc.

    Subject of the Form 4 insider transaction disclosure.

  • BHATIA MANISH H

    Director who purchased 20,000 shares for $1.2M on 2026-06-05.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QNTMed

Quantinuum vs. IonQ: Why One Major Wall Street Firm Says This Stock Is the Better Bet

Morgan Stanley upgraded Quantinuum (QNT) to overweight with a $68 price target, citing its leadership in quantum error correction and execution. IonQ (IONQ) kept at equal-weight with a $43 target. Quantinuum leads in error correction, while IonQ has advantages in manufacturability and scalability. Both companies are key players in the quantum computing sector, with Morgan Stanley forecasting a $100B market by 2040.

High

Morgan Stanley Names Quantinuum 'Top Pick,' Sets $62 Price Target

Morgan Stanley upgraded Quantinuum to 'Overweight' with a $62 price target, citing its technological edge in error-correction. Quantinuum shares rose 11.05% to $36.68. Morgan Stanley's analyst noted the company's lead in quantum computing technology, though commercialization remains years away. The stock trades below its 52-week high, and Wall Street's average target is $97.

$QNTHigh

Morgan Stanley Names New Top Quantum Computing Stock

Morgan Stanley upgraded Quantinuum (QNT) to Overweight, citing its leadership in quantum computing technology and execution. Shares rose 4.6% premarket. The bank sees a $100B+ market by 2040 but notes valuation gaps. Morgan Stanley lowered its price target to $62. It also rated IonQ (IONQ), Infleqtion (INFQ), and Xanadu (XNDU) as Equal-Weight.

Med

Morgan Stanley Upgrades Quantinuum, Projects $100 Billion Market

Morgan Stanley upgraded Quantinuum to Overweight, setting a $62 price target, 88% above its recent close. The bank forecasts the quantum computing market could exceed $100 billion annually by 2040, with $10 billion by 2030, contingent on fault-tolerant systems. Quantinuum's revenue is projected at $270 million in 2028 and $2 billion in 2030. The 2027 launch of Quantinuum's Sol system is seen as a key milestone.